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Monocytes are a heterogeneous cell population distinguished into three subsets with distinctive phenotypic and functional
properties: “classical” (CD14++CD16-), “intermediate” (CD14++CD16+), and “nonclassical” (CD14+CD16++). Monocyte
subsets play a pivotal role in many inflammatory systemic diseases including atherosclerosis (ATS). Only a low number of
studies evaluated monocyte behavior in patients affected by cardiovascular diseases, and data about their role in acute
aortic dissection (AAD) are lacking. Thus, the aim of this study was to investigate CD14++CD16-, CD14++CD16+, and
CD14+CD16++ cells in patients with Stanford-A AAD and in patients with carotid artery stenosis (CAS). Methods. 20
patients with carotid artery stenosis (CAS group), 17 patients with Stanford-A AAD (AAD group), and 17 subjects with
traditional cardiovascular risk factors (RF group) were enrolled. Monocyte subset frequency was determined by flow
cytometry. Results. Classical monocytes were significantly increased in the AAD group versus CAS and RF groups, whereas
intermediate monocytes were significantly decreased in the AAD group versus CAS and RF groups. Conclusions. Results of
this study identify in AAD patients a peculiar monocyte array that can partly explain depletion of T CD4+ lymphocyte
subpopulations observed in patients affected by AAD.
1. Introduction
Atherosclerosis (ATS) is amultifactorial disease [1] character-
ized by an inflammatory remodeling of the arterial wall.
Depending on size and site of vessels involved, ATS leads to a
wide range of cardiovascular diseases (CVDs) [2], including
ischemic heart disease, cerebrovascular disease, carotid artery
stenosis (CAS), abdominal aortic aneurism (AAA), acute aor-
tic dissection (AAD), and other conditions [3, 4]. Immune
response strongly affects the outcome of intraparietal inflam-
mation: Thelper (Th) 1 lymphocytes have beenmainly associ-
ated with plaque formation and Th2 lymphocytes with AAA,
whereas macrophages have been related to AAD [1, 5, 6].
Monocytes represent the circulating precursor of tissue
macrophages [7] and play an important role in atherogenesis,
being rapidly attracted by activated endothelial cells [8].
During an atherosclerotic process, their differentiation into
macrophages is associated with upregulation of phagocytic
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activity leading to lipid accumulation and formation of
typical foam cells [1]. Monocytes are a heterogeneous cell
population distinguished by the expression of the surface
markers CD14 (coreceptor for LPS) and CD16 (receptor for
FcγRIII) [9] into three subsets: “classical” (CD14++CD16-),
“intermediate” (CD14++CD16+), and “nonclassical” (CD14+
CD16++) [10]. Each monocyte subset possesses distinctive
phenotypic and functional properties and displays different
immune functions, distinguished by cytokine profiles and
phagocytic activity [11]. A low number of studies evaluated
monocyte behavior in patients affected by CVDs. Classical
monocytes have been independently associated with car-
diovascular events including death, myocardial infarction,
and stroke [12, 13]. Furthermore, experimental evidences
support the role of intermediate monocytes in atherooc-
clusive diseases [14], such as coronary artery disease
(CAD) [15, 16], cardioembolic stroke [17], CAS [18],
unstable angina [12, 18], and AAA [19]. However, to
our knowledge, data about the role of monocyte subsets
in AAD are still lacking.
Therefore, we evaluated CD14++CD16-, CD14++CD16+,
and CD14+CD16++ cells in patients with Stanford-A AAD
and in patients with CAS.
2. Materials and Methods
This was an observational retrospective study.
The population included in this study was composed
of 17 patients undergoing Stanford-A AAD surgical repair
at the Attilio Reale Heart and Great Vessels Department,
Policlinico Umberto I, “Sapienza” University of Rome
(AAD group). Patients were selected on the basis of the fol-
lowing inclusion criteria: (i) Stanford-A AAD; (ii) no history
of neoplasm or autoimmune, infectious, or inflammatory
systemic diseases; (iii) no presence of genetic syndromes
known to be responsible for aortic disease; and (iv) no family
history of aortic dissection or aneurysm.
A group of 20 patients with critical CAS (CAS group)
was selected among those undergoing carotid thrombo-
endo-arteriectomy (TEA) at the Department of Vascular
Surgery, Sant’Andrea Hospital, “Sapienza” University of
Rome. Patients were enrolled on the basis of the following
inclusion criteria: (i) critical carotid stenosis, defined as a
narrowing of the carotid lumen ≥ 70% [20, 21]; (ii) no car-
diac causes of stroke; (iii) no history of neoplasm or autoim-
mune or inflammatory systemic diseases; and (iv) no familiar
or personal history of aneurysms/dissection. All patients
underwent physical and neurological examinations, carotid
artery ultrasound, and angiography by magnetic resonance
imaging (MRI) or contrast tomography (CT).
Seventeen patients with traditional cardiovascular risk
factors attending the Department of Atherosclerosis and
Dyslipidemia, Sant’Andrea Hospital, “Sapienza” University
of Rome, were used as the control group (RF group). Patients
were selected on the basis of the following criteria: (i) no
acute cerebrovascular symptoms or history of cardiovascular
disease, (ii) no carotid stenosis > 20%, and (iii) no familiar or
personal history of aneurysms/dissection.
No significant differences regarding age (mean age ±
SD: 68 83 ± 4 11 years, 59 85 ± 11 01 years, and 62 59 ±
11 08 years for CAS, RF, and AAD, respectively), sex,
diabetes, hypertension, dyslipidemia, and body mass index
(BMI) were observed between CAS and RF groups.
AAD patients were matched with CAS and RF patients
for age, sex, diabetes, and BMI but not for hypertension
and dyslipidemia.
A venous blood sample was withdrawn from each patient
(just before surgery) and from each control, in order to iso-
late peripheral blood mononuclear cells (PBMCs) by density
gradient centrifugation (Lympholyte, Cedarlane, Hornby,
CA). (Since Attilio Reale Heart and great Vessels Department
is an hub reference center for AAD, all patients underwent to
surgery within 6 hours from the onset of the symptoms and
blood samples were collected within this time).
Monocyte subsets were analyzed by flow cytometry as
previously described [22–24] using the following antibodies:
CD14 FITC (BD Biosciences, San Jose, CA, USA), CD16
APC (BD Biosciences, San Jose, CA, USA), and HLA-DR
PE (BD Biosciences, San Jose, CA, USA). Briefly, cells were
first visualized on FSC vs. SSC, and an ample gate was drawn
around the monocyte cloud to exclude the majority of debris
and lymphocytes. These cells were then viewed on a CD14 vs.
CD16 plot. Moreover, the presence of natural killer (NK)
cells, most of which are CD16-positive and could interfere
with CD16+ monocyte count, was checked by HLA-DR
antibody; accordingly, HLA-DR-negative NK cells were
excluded. Monocyte subsets CD14+CD16−, CD14+CD16+,
and CD14+CD16++ were, therefore, defined according to
the surface expression of CD14 and CD16 [23, 9] (Figure 1).
On the basis of the number of PBMC available, it was
possible to test also CD4+ T lymphocytes in 6 patients of
the CAS group, in 6 with RF, and in 10 with AAD. In the
10 AAD patients, immunohistochemistry of aortic speci-
mens collected during surgery was performed as previously
described [25].
FACS analysis was performed using a FACSCalibur
cytometer (Becton-Dickinson) equipped with Cell Quest
software. Isotype controls were used as compensation
controls and to confirm antibody specificity.
All the statistical procedures were performed by Graph-
Pad Prism 4 software (GraphPad Software Inc.).
The study was performed according to the principles of
the Declaration of Helsinki and was approved by the ethics
committee of the Faculty of Medicine.
Written informed consent was obtained from each
patient or from an authorized family member.
3. Results and Discussion
3.1. Results
3.1.1. Monocytes. Classical monocytes were significantly
increased in the AAD group versus CAS and RF groups
(p = 0 0342 and p = 0 0422, respectively), whereas intermedi-
ate monocytes were significantly decreased in the AAD
group versus CAS and RF groups (p = 0 0494 and p =
0 0211, respectively). In particular, both intermediate and
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nonclassical monocytes progressively increased from AAD to
RF, although any significant difference was observed regard-
ing the nonclassical subset (Table 1, Figure 2). No significant
differences were observed between CAS and RF groups for all
monocyte subsets.
3.1.2. Lymphocyte Subpopulations. A significant decrease of
CD4+ T lymphocyte percentage (p = 0 05) was observed
in AAD (mean ± SD: 31 04 ± 17 92; median: 30.00) versus
CAS (mean ± SD: 50 63 ± 19 34; median: 55.35). No signif-
icant differences were observed between CAS and RF
(mean ± SD38 43 ± 14 36; median 39.00) and between
AAD and RF.
3.1.3. Immunohistochemistry. Data regarding immunohisto-
chemistry are reported in Table 2. In 8/10 AAD samples, an
inflammatory infiltrate was observed within the aortic wall.
In 7/8 samples, macrophages were the main population
infiltrating the arterial wall, whereas only in one patient was
observed a low infiltrate of T CD4+ lymphocytes.
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Figure 1: Representative flow cytometry strategy. Cells are visualized on FSC vs. SSC, and gate R1 is drawn around the monocyte
cloud (a). These cells are then viewed on a CD14 (FITC, FL1-H) vs. CD16 (APC, FL4-H) plot, and gate R2 is drawn around the
monocyte cloud (b). Gate R2 cells are viewed on a CD16 (APC, FL4-H) vs. HLA-DR (PE, FL2-H) plot, and HLA-DR-negative NK cells
were excluded drawing R3 gate (c). Then, R3 monocyte population is viewed again on a CD14 (FITC, FL1-H) vs. CD16 (APC, FL4-H)
plot, and CD14++CD16- (gate R4), CD14++CD16+ (gate R5), and CD14+CD16++ (gate R6) cells are defined according to the surface
expression of CD14 and CD16 (d).
Table 1: Percentage of monocyte subsets in CAS, AAD, and RF groups.
Group CAS (n = 20)
Mean ± SD M
Group AAD (n = 17)
Mean ± SD M
Group RF (n = 17)
Mean ± SD M
Classical monocytes 93 05 ± 4 21 93.74 95 37 ± 4 04 97.11 91 11 ± 7 68 92.67
Intermediate monocytes 5 78 ± 3 59 5.45 3 69 ± 3 23 2.89 6 99 ± 4 96 7.25
Nonclassical monocytes 1 17 ± 1 20 0.65 0 94 ± 1 19 0.45 1 90 ± 3 84 0.54
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3.2. Discussion. Our results demonstrated that patients
affected by AAD show a peculiar monocyte pattern charac-
terized by elevated classic and reduced intermediate cell sub-
sets, which predispose them to a prevalent natural immune
response. Moreover, we observed that CAS and AAD
patients displayed an opposite monocyte array, confirming
that immune response plays a pivotal role in driving athero-
sclerotic parietal remodeling toward occlusion or rupture. In
this field, it has been demonstrated that a prevalent CD4+
immune response directs subintimal inflammation toward
plaque formation, whereas a prevalent innate macrophage
activation underlies medial degeneration and aortic rupture
in Stanford-A AAD patients with no genetic predisposition
[1, 6].
We, indeed, considered AAD and asymptomatic critical
CAS as the opposite sides of the same ATS diseases, in which
immune response drives parietal remodeling toward rupture
or stable occlusion.
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Figure 2: FACS analysis of monocyte subsets in CAS, RF, and AAD groups. Data were expressed as the percentage of cells (a) and the
number of events (b). The 25 and 75 percentiles, median, minimal, and maximal are shown. Statistical analysis: Mann–Whitney
nonparametric test. ∗p < 0 05.
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Monocytes represent a systemic reservoir of myeloid
precursors for renewal of tissue macrophages and dendritic
cells, but they also exert effector/antigen-presenting cell
and regulatory functions. Macrophages are the main cells
involved in the innate immune response and play a crucial
role in the inflammatory process underlying ATS [26].
These cells, indeed, express an array of inflammatory fac-
tors, as well as matrix metalloproteinases (MMPs), which
are responsible for maintaining intraparietal inflammation
and degrading extracellular matrix [27]. Their activation
has been related to myocardial infarction, stroke, and
CAS [28]. Moreover, several studies indicated, both in
mice and in humans, that macrophage recall and their
activation represent key events in the early phases of
AAD [6].
Interestingly, monocytes are able to trigger and polarize
T cell-mediated immune response [29–31]. In particular,
intermediate monocytes exert proinflammatory actions
[10, 32] and have been reported to favor T cell differenti-
ation toward Th1 and Th17 [33].
Experimental evidences support the role of intermediate
monocytes in atheroocclusive diseases [22–24], such as
symptomatic and asymptomatic CAS, cardioembolic stroke,
and unstable angina [12, 17, 18]. Our results confirmed a
high percentage of intermediate monocytes in CAS patients,
whereas such subset was decreased in the AAD group versus
both CAS and RF. This suggests that such depletion is specif-
ically related to aortic rupture and can at least in part explain
the lack of T CD4+ subpopulations which characterizes
Stanford-A AAD [6, 34]. We, indeed, confirm that CD4+ T
lymphocytes are significantly reduced in peripheral blood
of AAD patients in comparison with CAS [6]. Moreover, a
prevalent macrophage infiltrate was found within the tunica
media in aortic samples, whereas T CD4+ lymphocytes were
poorly represented.
In the AAD group, a significant increase of classic mono-
cytes was documented versus both CAS and RF. Monocyte
CD14++CD16- are mainly involved in natural response
against pathogens. Furthermore, this subset has been related
to the inflammatory process occurring in ATS [35]. The
increase of such pattern in Stanford-A AAD patients strongly
confirms that inflammation underlies also ascending aortic
wall rupture in patients with no genetic predisposition
and supports the hypothesis of a microbial contribution
to AAD [36].
4. Conclusion
This study seems of particular interest, since to our knowl-
edge, it is the first report about monocyte subsets in AAD.
We found that Stanford-A AAD patients with no genetic
predisposition display a peculiar monocyte pattern, which
strongly differs from that observed in the CAS group.
We, therefore, can speculate that monocytes, particularly
CD14++CD16+ cells, can represent the link between innate
and adaptive immunity and can contribute to drive immune
response toward a matrix degrading natural response.
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